Analysis of Liquidity Ratios
Quarterly Data
Liquidity ratios measure the company ability to meet its short-term obligations.
Liquidity Ratios (Summary)
UnitedHealth Group Inc., liquidity ratios (quarterly data)
Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
- Liquidity Ratios Overview
- The current ratio demonstrated a gradual upward trend over the analyzed period, starting from 0.74 and reaching a peak of 0.91 in the third quarter of 2024 before slightly declining to 0.82 by the third quarter of 2025. This indicates a moderate improvement in the company's ability to cover its short-term liabilities with current assets, reflecting a strengthening liquidity position through most periods.
- Similarly, the quick ratio, which excludes inventory from current assets, followed a comparable trajectory. It started at 0.68, rose steadily to a high of 0.83 in the third quarter of 2024, and then experienced a decrease to 0.74 by the third quarter of 2025. This pattern suggests an enhancement in near-cash assets relative to current liabilities, supporting the observation of improved liquidity.
- The cash ratio displayed more volatility compared to the other liquidity measures. It began at 0.33, peaked at 0.46 in the third quarter of 2022, but then fluctuated downward with intermittent rises, ultimately falling to 0.26 by the third quarter of 2025. This indicates less stability in the company's most liquid assets (cash and equivalents) relative to its current liabilities, suggesting cautious cash management or changing cash flow dynamics.
- Insight Summary
- Overall, the data suggests that while the company improved its general and quick liquidity positions over the examined timeframe, it experienced variability in immediate cash availability. The divergence in the cash ratio’s trend compared to the current and quick ratios may warrant further investigation into cash flow management practices or short-term investment strategies. Despite the declines in cash ratio toward the end of the period, the current and quick ratios maintain sound levels that imply the company remains capable of meeting its short-term obligations.
Current Ratio
UnitedHealth Group Inc., current ratio calculation (quarterly data)
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||
| Current assets | 95,067) | 93,699) | 96,285) | 85,779) | 92,258) | 92,038) | 88,942) | 78,437) | 91,905) | 89,869) | 93,895) | 69,069) | 82,937) | 68,356) | 69,029) | 61,758) | 61,610) | 58,916) | 59,508) | ||||||
| Current liabilities | 115,526) | 110,781) | 113,471) | 103,769) | 101,565) | 104,670) | 104,431) | 99,054) | 114,179) | 112,981) | 116,482) | 89,237) | 100,935) | 88,698) | 88,170) | 78,292) | 79,575) | 76,557) | 80,641) | ||||||
| Liquidity Ratio | |||||||||||||||||||||||||
| Current ratio1 | 0.82 | 0.85 | 0.85 | 0.83 | 0.91 | 0.88 | 0.85 | 0.79 | 0.80 | 0.80 | 0.81 | 0.77 | 0.82 | 0.77 | 0.78 | 0.79 | 0.77 | 0.77 | 0.74 | ||||||
| Benchmarks | |||||||||||||||||||||||||
| Current Ratio, Competitors2 | |||||||||||||||||||||||||
| Abbott Laboratories | 1.70 | 1.82 | 1.78 | 1.67 | 1.60 | 1.68 | 1.60 | 1.64 | 1.74 | 1.64 | 1.68 | 1.63 | 1.86 | 2.01 | 1.85 | 1.85 | 1.83 | 1.79 | 1.75 | ||||||
| Elevance Health Inc. | 1.56 | 1.44 | 1.43 | 1.45 | 1.50 | 1.49 | 1.37 | 1.44 | 1.41 | 1.44 | 1.43 | 1.40 | 1.35 | 1.36 | 1.36 | 1.47 | 1.48 | 1.49 | 1.57 | ||||||
| Intuitive Surgical Inc. | 4.73 | 5.17 | 4.98 | 4.07 | 4.30 | 5.15 | 5.55 | 4.76 | 5.31 | 5.22 | 5.26 | 4.40 | 5.10 | 5.36 | 5.22 | 5.08 | 5.58 | 5.99 | 6.71 | ||||||
| Medtronic PLC | 1.90 | 1.84 | 2.13 | 2.03 | 2.30 | 2.29 | 2.42 | 2.39 | 1.76 | 1.76 | 1.58 | 1.86 | 2.61 | 2.91 | 2.89 | 2.65 | 2.10 | 2.16 | 1.87 | ||||||
Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
1 Q3 2025 Calculation
Current ratio = Current assets ÷ Current liabilities
= 95,067 ÷ 115,526 = 0.82
2 Click competitor name to see calculations.
The analyzed financial data reveals several notable trends in the company's short-term financial position over the observed quarterly periods. The figures for current assets and current liabilities exhibit fluctuations that impact the company's liquidity as reflected in the current ratio.
- Current Assets
- The current assets demonstrate variability, starting at approximately $59.5 billion in the first quarter of 2021 and showing an upward trend with some volatility. The highest value recorded within the period is around $93.9 billion in the first quarter of 2023. Despite occasional declines such as toward the fourth quarter of 2022 and again near the end of 2023, current assets generally remain robust, frequently exceeding $85 billion in the most recent quarters.
- Current Liabilities
- Current liabilities consistently exceed current assets in every quarter, indicating ongoing liquidity pressure. The liabilities show a pattern of gradual increase over time, rising from about $80.6 billion in early 2021 to peaks above $116 billion in early 2023. Although there are some declines and fluctuations thereafter, liabilities remain near or above $100 billion in the latest quarters, reflecting significant obligations due within a year.
- Current Ratio
- The current ratio remains below 1.0 across all quarters, confirming that current liabilities surpass current assets and pointing to potential short-term liquidity concerns. However, the ratio indicates a mild improvement over time—from a low of 0.74 in early 2021 to a peak near 0.91 in the third quarter of 2024. This gradual increase suggests an improving ability to cover short-term liabilities with current assets, though the ratio dips again toward the end of the period, stabilizing in the range of 0.82 to 0.85.
- Overall Analysis
- The data reflects a company managing significant short-term liabilities with fluctuating but generally growing current assets. The improvement in the current ratio over time suggests enhanced liquidity management despite recurring periods when liabilities heavily outweigh assets. The persistent sub-unity current ratio signals ongoing short-term liquidity risk, which warrants continued monitoring to ensure that obligations can be met without financial strain.
Quick Ratio
UnitedHealth Group Inc., quick ratio calculation (quarterly data)
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||
| Cash and cash equivalents | 27,210) | 28,596) | 30,717) | 25,312) | 32,400) | 26,286) | 28,414) | 25,427) | 38,915) | 41,813) | 41,913) | 23,365) | 38,845) | 24,612) | 25,482) | 21,375) | 21,085) | 19,832) | 19,955) | ||||||
| Short-term investments | 3,404) | 3,424) | 3,574) | 3,801) | 4,734) | 5,037) | 4,296) | 4,201) | 5,182) | 4,466) | 4,584) | 4,546) | 3,682) | 3,352) | 2,914) | 2,532) | 2,786) | 2,729) | 2,962) | ||||||
| Accounts receivable, net | 22,672) | 24,142) | 26,936) | 22,365) | 20,024) | 23,115) | 27,197) | 21,276) | 20,673) | 17,952) | 22,414) | 17,681) | 17,047) | 18,718) | 18,871) | 14,216) | 14,152) | 14,587) | 15,980) | ||||||
| Other current receivables, net | 32,762) | 28,582) | 26,022) | 26,089) | 27,461) | 26,762) | 19,284) | 17,694) | 17,752) | 16,131) | 14,696) | 12,769) | 13,684) | 12,439) | 11,994) | 13,866) | 14,080) | 12,630) | 11,546) | ||||||
| Assets under management | —) | —) | —) | —) | —) | 3,414) | 3,619) | 3,755) | 3,616) | 3,623) | 3,837) | 4,087) | 4,022) | 4,017) | 4,155) | 4,449) | 4,304) | 4,198) | 4,094) | ||||||
| Total quick assets | 86,048) | 84,744) | 87,249) | 77,567) | 84,619) | 84,614) | 82,810) | 72,353) | 86,138) | 83,985) | 87,444) | 62,448) | 77,280) | 63,138) | 63,416) | 56,438) | 56,407) | 53,976) | 54,537) | ||||||
| Current liabilities | 115,526) | 110,781) | 113,471) | 103,769) | 101,565) | 104,670) | 104,431) | 99,054) | 114,179) | 112,981) | 116,482) | 89,237) | 100,935) | 88,698) | 88,170) | 78,292) | 79,575) | 76,557) | 80,641) | ||||||
| Liquidity Ratio | |||||||||||||||||||||||||
| Quick ratio1 | 0.74 | 0.76 | 0.77 | 0.75 | 0.83 | 0.81 | 0.79 | 0.73 | 0.75 | 0.74 | 0.75 | 0.70 | 0.77 | 0.71 | 0.72 | 0.72 | 0.71 | 0.71 | 0.68 | ||||||
| Benchmarks | |||||||||||||||||||||||||
| Quick Ratio, Competitors2 | |||||||||||||||||||||||||
| Abbott Laboratories | 1.09 | 1.14 | 1.09 | 1.05 | 1.00 | 1.02 | 0.95 | 1.00 | 1.04 | 1.00 | 1.07 | 1.06 | 1.22 | 1.33 | 1.21 | 1.28 | 1.25 | 1.19 | 1.16 | ||||||
| Elevance Health Inc. | 1.43 | 1.32 | 1.31 | 1.32 | 1.34 | 1.32 | 1.23 | 1.30 | 1.29 | 1.32 | 1.31 | 1.27 | 1.21 | 1.22 | 1.23 | 1.33 | 1.33 | 1.35 | 1.43 | ||||||
| Intuitive Surgical Inc. | 3.42 | 3.90 | 3.73 | 3.00 | 3.21 | 3.94 | 4.31 | 3.83 | 4.44 | 4.36 | 4.30 | 3.56 | 4.19 | 4.49 | 4.40 | 4.34 | 4.66 | 5.12 | 5.76 | ||||||
| Medtronic PLC | 1.19 | 1.17 | 1.35 | 1.31 | 1.46 | 1.42 | 1.51 | 1.54 | 1.18 | 1.18 | 1.01 | 1.30 | 1.87 | 2.07 | 2.06 | 1.91 | 1.58 | 1.63 | 1.37 | ||||||
Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
1 Q3 2025 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 86,048 ÷ 115,526 = 0.74
2 Click competitor name to see calculations.
The analysis of the quarterly financial data over the examined periods reveals notable trends in liquidity and short-term financial health.
- Total Quick Assets
- The total quick assets exhibit an overall upward trend across the periods. Starting at approximately $54,537 million in the first quarter of 2021, these assets increased steadily with some fluctuations. Significant jumps are observed around the third quarter of 2022 and the first quarter of 2023, reaching values above $87,000 million by early 2025. Despite intermittent declines, the general direction is growth, indicating an improvement in highly liquid assets available to meet immediate obligations.
- Current Liabilities
- Current liabilities have also trended upward over the timeframe, beginning at about $80,641 million in the first quarter of 2021 and rising to exceed $115,000 million by the third quarter of 2025. The liabilities increased in a relatively steady manner with occasional dips, notably in the fourth quarter of 2022 and the first quarter of 2024. The rises in liabilities have generally paralleled the increases in quick assets but at a somewhat faster pace, leading to changes in liquidity ratios.
- Quick Ratio
- The quick ratio, representing the company's ability to cover short-term liabilities with its most liquid assets, fluctuated between 0.68 and 0.83. From early 2021 to late 2021, the ratio hovered around 0.68 to 0.72, indicating moderate liquidity. A peak is seen in the third quarter of 2024, reaching 0.83, suggesting an improved capacity to meet short-term obligations. However, the ratio slightly declined in subsequent periods, settling near 0.74 by the third quarter of 2025. This implies that despite growth in quick assets, increasing current liabilities have tempered the overall liquidity improvement.
In summary, the financial data reflects growth in both liquid assets and short-term liabilities, with the company maintaining a quick ratio generally below 1.0 throughout the period. This suggests ongoing reliance on current liabilities to finance operations, but the gradual increase in the quick ratio during certain periods indicates efforts toward strengthening liquidity positions.
Cash Ratio
UnitedHealth Group Inc., cash ratio calculation (quarterly data)
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||||||||||||||||||||||
| Cash and cash equivalents | 27,210) | 28,596) | 30,717) | 25,312) | 32,400) | 26,286) | 28,414) | 25,427) | 38,915) | 41,813) | 41,913) | 23,365) | 38,845) | 24,612) | 25,482) | 21,375) | 21,085) | 19,832) | 19,955) | ||||||
| Short-term investments | 3,404) | 3,424) | 3,574) | 3,801) | 4,734) | 5,037) | 4,296) | 4,201) | 5,182) | 4,466) | 4,584) | 4,546) | 3,682) | 3,352) | 2,914) | 2,532) | 2,786) | 2,729) | 2,962) | ||||||
| Assets under management | —) | —) | —) | —) | —) | 3,414) | 3,619) | 3,755) | 3,616) | 3,623) | 3,837) | 4,087) | 4,022) | 4,017) | 4,155) | 4,449) | 4,304) | 4,198) | 4,094) | ||||||
| Total cash assets | 30,614) | 32,020) | 34,291) | 29,113) | 37,134) | 34,737) | 36,329) | 33,383) | 47,713) | 49,902) | 50,334) | 31,998) | 46,549) | 31,981) | 32,551) | 28,356) | 28,175) | 26,759) | 27,011) | ||||||
| Current liabilities | 115,526) | 110,781) | 113,471) | 103,769) | 101,565) | 104,670) | 104,431) | 99,054) | 114,179) | 112,981) | 116,482) | 89,237) | 100,935) | 88,698) | 88,170) | 78,292) | 79,575) | 76,557) | 80,641) | ||||||
| Liquidity Ratio | |||||||||||||||||||||||||
| Cash ratio1 | 0.26 | 0.29 | 0.30 | 0.28 | 0.37 | 0.33 | 0.35 | 0.34 | 0.42 | 0.44 | 0.43 | 0.36 | 0.46 | 0.36 | 0.37 | 0.36 | 0.35 | 0.35 | 0.33 | ||||||
| Benchmarks | |||||||||||||||||||||||||
| Cash Ratio, Competitors2 | |||||||||||||||||||||||||
| Abbott Laboratories | 0.53 | 0.54 | 0.53 | 0.56 | 0.52 | 0.52 | 0.47 | 0.53 | 0.54 | 0.57 | 0.66 | 0.66 | 0.74 | 0.75 | 0.65 | 0.78 | 0.75 | 0.71 | 0.67 | ||||||
| Elevance Health Inc. | 0.89 | 0.79 | 0.79 | 0.85 | 0.90 | 0.86 | 0.82 | 0.87 | 0.90 | 0.92 | 0.91 | 0.86 | 0.87 | 0.86 | 0.86 | 0.95 | 0.97 | 0.97 | 1.08 | ||||||
| Intuitive Surgical Inc. | 2.72 | 3.15 | 2.93 | 2.30 | 2.52 | 3.20 | 3.49 | 3.15 | 3.86 | 3.77 | 3.59 | 2.90 | 3.50 | 3.78 | 3.58 | 3.66 | 3.98 | 4.42 | 5.04 | ||||||
| Medtronic PLC | 0.67 | 0.66 | 0.76 | 0.74 | 0.85 | 0.80 | 0.87 | 0.88 | 0.77 | 0.79 | 0.63 | 0.85 | 1.26 | 1.37 | 1.36 | 1.27 | 1.17 | 1.18 | 0.99 | ||||||
Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
1 Q3 2025 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 30,614 ÷ 115,526 = 0.26
2 Click competitor name to see calculations.
- Total Cash Assets
- The total cash assets exhibited fluctuations over the observed quarters. Beginning at approximately $27 billion in early 2021, cash holdings saw a gradual increase, peaking near $46.5 billion in late 2022. Following this peak, the cash assets generally trended downward with some recovery phases, ending around $30.6 billion by the third quarter of 2025. This indicates a pattern of cash accumulation followed by periods of strategic utilization or reallocation.
- Current Liabilities
- Current liabilities showed a consistent upward trend throughout the period. Starting from roughly $80.6 billion in the first quarter of 2021, liabilities increased steadily, reaching over $115 billion by the third quarter of 2025. Despite some modest short-term declines, the overall growth in liabilities signals rising short-term obligations or operational scaling that may require ongoing management attention.
- Cash Ratio
- The cash ratio, reflecting the company's liquidity position, fluctuated within a relatively narrow range. It began near 0.33 in early 2021, increased to a high of approximately 0.46 in late 2022, and subsequently declined towards the end of the timeframe, reaching about 0.26 by the third quarter of 2025. This decline in liquidity ratio toward the latter periods suggests a decrease in readily available cash relative to current liabilities, which could imply higher reliance on other liquidity sources or increased short-term financial obligations.
- Summary Insights
- Overall, the data demonstrates a period of growing cash reserves that was followed by utilization or reduction in cash assets, coinciding with steadily rising current liabilities. The cash ratio's peak and subsequent decline imply a shift in liquidity strategy or changes in operational financing. Continuous monitoring of cash levels against liabilities will be crucial to ensure sustained liquidity and financial stability.